Determination of levetiracetam in human plasma by dispersive liquid-liquid microextraction followed by gas chromatography-mass spectrometry
dc.contributor.author | Steinhorst Alcantara, Greyce Kelly | |
dc.contributor.author | Calixto, Leandro Augusto [UNIFESP] | |
dc.contributor.author | Beraldo de Moraes, Luiz Alberto | |
dc.contributor.author | Costa Queiroz, Regina Helena | |
dc.contributor.author | Moraes de Oliveira, Anderson Rodrigo | |
dc.contributor.author | de Gaitani, Cristiane Masetto | |
dc.date.accessioned | 2019-01-21T10:29:45Z | |
dc.date.available | 2019-01-21T10:29:45Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Levetiracetam (LEV) is an antiepileptic drug that is clinically effective in generalized and partial epilepsy syndromes. The use of this drug has been increasing in clinical practice and intra- or -interindividual variability has been exhibited for special population. For this reason, bioanalytical methods are required for drug monitoring in biological matrices. So this work presents a dispersive liquid-liquid microextraction method followed by gas chromatography-mass spectrometry (DLLME-GC-MS) for LEV quantification in human plasma. However, due to the matrix complexity a previous purification step is required. Unlike other pretreatment techniques presented in the literature, for the first time, a procedure employing ultrafiltration tubes Amicon (R) (10 kDa porous size) without organic solvent consumption was developed. GC-MS analyses were carried out using a linear temperature program, capillary fused silica column, and helium as the carrier gas. DLLME optimized parameters were type and volume of extraction and dispersing solvents, salt addition, and vortex agitation time. Under chosen parameters (extraction solvent: chloroform, 130 mu L | en |
dc.description.abstract | dispersing solvent: isopropyl alcohol, 400 mu L | en |
dc.description.abstract | no salt addition and no vortex agitation time), the method was completely validated and all parameters were in agreement with the literature recommendations. LEV was quantified in patient's plasma sample using less than 550 mu L of organic solvent. | en |
dc.description.affiliation | Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, 14040-903 Ribeirão Preto, SP, Brazil | |
dc.description.affiliation | Department of Exact and Earth Sciences, Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, 09972-270 Diadema, SP, Brazil | |
dc.description.affiliation | Departament of Chemistry, Faculty of Philosophy, Sciences and Letters of Ribeirão Preto, University of São Paulo, 14040-901 Ribeirão Preto, SP, Brazil | |
dc.description.affiliation | Department of Clinical Analysis, Toxicology and Food Science, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, 14040-903 Ribeirão Preto, SP, Brazil | |
dc.description.affiliationUnifesp | Department of Exact and Earth Sciences, Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, 09972-270 Diadema, SP, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Sao Paulo Research Foundation (FAPESP) [2012/07210-8] | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) | |
dc.description.sponsorship | Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) | |
dc.description.sponsorshipID | FAPESP: 2012/07210-8 | |
dc.identifier | http://dx.doi.org/10.1155/2016/5976324 | |
dc.identifier.citation | Journal Of Analytical Methods In Chemistry. London, 2016. | |
dc.identifier.doi | 10.1155/2016/5976324 | |
dc.identifier.file | WOS000386837800001.pdf | |
dc.identifier.issn | 2090-8865 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/49371 | |
dc.identifier.wos | WOS:000386837800001 | |
dc.language.iso | eng | |
dc.publisher | Univ Sao Paulo, Inst Psiquiatria | |
dc.relation.ispartof | Journal Of Analytical Methods In Chemistry | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Solid-Phase Extraction | en |
dc.subject | Hplc-Uv | en |
dc.subject | Antiepileptic Drugs | en |
dc.subject | Organic-Compounds | en |
dc.subject | Human Urine | en |
dc.subject | Performance | en |
dc.subject | Water | en |
dc.subject | Samples | en |
dc.subject | Zonisamide | en |
dc.subject | Serum | en |
dc.title | Determination of levetiracetam in human plasma by dispersive liquid-liquid microextraction followed by gas chromatography-mass spectrometry | en |
dc.type | info:eu-repo/semantics/article |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- WOS000386837800001.pdf
- Tamanho:
- 1.84 MB
- Formato:
- Adobe Portable Document Format
- Descrição: